comparemela.com

Latest Breaking News On - Bleeding academic research consortium - Page 1 : comparemela.com

Cancer and High Bleeding Risk, Increased Risk for Clinical Events Following PCI

Among patients with high bleeding risk, following PCI those with cancer have higher risk for clinical events than those without cancer.

Ticagrelor monotherapy reduces bleeding risk following percutaneous coronary intervention

1. Clinically relevant bleeding was significantly lower with ticagrelor monotherapy than in the ticagrelor plus aspirin group. 2. Major cardiovascular and cerebrovascular events were comparable in both groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Dual antiplatelet therapy (DAPT) is the current standard of care for acute coronary syndrome (ACS) following percutaneous coronary intervention (PCI).

Real-world 30-day data show noninferiority of new TAVR valve vs other contemporary valves

Real-world 30-day data show noninferiority of new TAVR valve vs other contemporary valves
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

EuroPCR 2024: 5-Month Ticagrelor Monotherapy Success in ACS Post 1-Month DAPT

EuroPCR 2024: 5-Month Ticagrelor Monotherapy Success in ACS Post 1-Month DAPT
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

De-escalation strategy may be preferred to 12-month DAPT in PCI with drug-coated balloon

De-escalation strategy may be preferred to 12-month DAPT in PCI with drug-coated balloon
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.